RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Cash from financing

ABBOTT LABORATORIESABT

Market cap
$221.4B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024-5,404-23.79%
Dec 31, 2023-7,091-7.14%
Dec 31, 2022-7,636+38.99%
Dec 31, 2021-5,494+97.70%
Dec 31, 2020-2,779-35.21%
Dec 31, 2019-4,289-58.72%
Dec 31, 2018-10,391+96.76%
Dec 31, 2017-5,281-147.38%
Dec 31, 201611,147-598.52%
Dec 31, 2015-2,236-18.45%
Dec 31, 2014-2,742-59.05%
Dec 31, 2013-6,696-1035.07%
Dec 31, 2012716-111.89%
Dec 31, 2011-6,023+453.76%
Dec 31, 2010-1,088

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)